<DOC>
	<DOCNO>NCT01642485</DOCNO>
	<brief_summary>Moxifloxacin routinely use probe confirm assay sensitivity thorough electrocardiogram ( ECG ) study . It show meal shortens QT interval , may affect pharmacokinetics ( PK ) and/or pharmacodynamics ( PD ) study drug . However , publish data clarify issue . There also paucity data investigate ethnic difference effect medicine QTc . The aim study compare effect different food content placebo change ECG demonstrate effect insulin , C-peptide glucose ECG . This do give different treatment separate day , include intravenous insulin , high carbohydrate breakfast [ &gt; 70 % ] , calorie reduce low carbohydrate American FDA standard breakfast . Moxifloxacin 400 mg use positive control give without food Caucasian Japanese volunteer investigate racial difference .</brief_summary>
	<brief_title>Food Insulin Effect QT/QTC Interval ECG</brief_title>
	<detailed_description>This study initially perform 24 healthy Caucasian Japanese volunteer option increase sample size 54 volunteer . The decision increase sample size 32 base standard deviation ECG interval observe first 24 volunteer . This analysis perform independent statistician blind condition . Each volunteer participate 2 period . Each period consist 1 baseline day ( D-1 ) follow 3 study day ( D1 - D3 ) various food effect drug treatment placebo administer . All volunteer receive treatment . Moxifloxacin always give D3 prevent carryover effect minimum washout period 3 day 2 period . How well treatment ( insulin/glucose , high carbohydrate breakfast , calorie reduce breakfast moxifloxacin ) tolerate volunteer assessed side effect note . We compare effect various treatment Caucasian Japanese volunteer . Moxifloxacin placebo give volunteer mouth , i.e . ask swallow water . The different type breakfast provide volunteer ask eat . Insulin glucose administer intravenously ( Insulin/glucose clamp ) . Hence , study perform open-label design . This study conduct single site study Richmond Pharmacology/ St George 's University London .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>1 . Healthy male female , 20 45 year old 2 . Signed ICF 3 . Japanese descendant four Japanese grandparent , carry Japanese passport outside Japan 5 year prior screen 4 . The Caucasian light brown skin pigmentation ; straight wavy curly hair ; indigenous Europe , northern Africa , western Asia , India . The study may also include Caucasians North America , Australia South Africa 5 . No clinical finding physical examination 6 . Body mass index ( BMI ) = 18 25 kg/m2 , body weight least 48 kg . 7 . Systolic blood pressure 90145 mmHg , diastolic blood pressure 4090 mmHg , heart rate 4090 bpm 8 . Triplicate 12 lead ECG without clinically relevant abnormality 9 . 24 hour 12 lead Holter ECG without clinically relevant abnormality 10 . Haematology , biochemistry urinalysis within normal range 11 . Must agree use acceptable method contraception 1 . History clinical evidence disease and/or existence surgical medical condition might interfere absorption , distribution , metabolism excretion study drug 2 . History clinically significant syncope . 3 . Family history sudden death . 4 . Family history premature cardiovascular death . 5 . Family history congenital long QT syndrome Brugada 's syndrome . 6 . History arrhythmias ischemic heart disease 7 . Conditions predispose electrolyte imbalance ( e.g . alter nutritional state , chronic vomiting , anorexia nervosa , bulimia nervosa ) . 8 . Abnormal ECG standard 12lead ECG 24hour 12 lead Holter ECG 9 . Abnormal rhythm , conduction morphology rest ECG , : Sinus node dysfunction . Clinically significant PR ( PQ ) interval prolongation . Intermittent second third degree AV block . Incomplete complete bundle branch block . Abnormal T wave morphology . Prolonged QTcB &gt; 450 msec shorten QTcB &lt; 350 msec family history long QT syndrome . 10 . Abnormal blood glucose result ( blood glucose &gt; 7.8mmol/l ) 11 . Significant family history diabetes mellitus . 12 . Significantly elevate fast blood glucose level 13 . Signs and/or symptom acute illness fourweek period prior screen . 14 . Veins unsuitable intravenous puncture cannulation either arm 15 . Known hypersensitivity medicine administer trial . 16 . Treatment prescribed medication 2 week prior first baseline day . 17 . Treatment overthecounter ( OTC ) medication 2 week prior first baseline day . 18 . Treatment vitamins and/or mineral within 48 hour prior first baseline day . 19 . Treatment another investigational drug within 4 week prior dose participate 3 investigational drug study within year prior dose . 20 . Positive urine drug screen ( amphetamine , benzodiazepine , cocaine , cannabinoids , opiate , barbiturates methadone ) alcohol breath test 21 . History clinical evidence alcoholism ( regular weekly alcohol intake 14 unit female 21 unit male ) drug abuse ( compulsive , repetitive and/or chronic use drug substance without problem relate use and/or stop reduction dose lead withdrawal symptom ) 22 . Excessive caffeine consumption ( â‰¥800 mg per day ) 23 . Smoking within 3 month prior screen 24 . Loss 250 mL blood within 3 month prior screen . 25 . Positive result hepatitis serology , except vaccinated subject . 26 . Positive result HIV serology . 27 . Any circumstance condition , may affect full participation study compliance protocol . 28 . Legal incapacity limit legal capacity .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>Insulin clamp</keyword>
	<keyword>Glucose clamp</keyword>
	<keyword>Moxifloxacin</keyword>
	<keyword>Fed</keyword>
	<keyword>Fasted</keyword>
	<keyword>QT/QTC interval</keyword>
	<keyword>TQT</keyword>
	<keyword>ECG</keyword>
	<keyword>Meal effect</keyword>
	<keyword>C Peptide</keyword>
	<keyword>Japanese Caucasian bridging</keyword>
	<keyword>TQT bridging</keyword>
	<keyword>FDA standard breakfast</keyword>
	<keyword>Adaptive study design</keyword>
</DOC>